Deccan Health Care

17.80
-0.92
(-4.91%)
Market Cap
41.65 Cr
EPS
0.80
PE Ratio
37.44
Dividend Yield
0.00 %
52 Week High
39.10
52 Week Low
16.00
PB Ratio
0.42
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,836.30
#1 23,709.12
48.19
#1 2,295.80
11.52
#1 362
81.24
59.61
1,001.90
10,283.13
72.41
568.60
20.11
120
35.77
47.05
1,674.70
8,588.05
56.61
1,216.80
4.59
129
15.38
52.26
914.20
4,844.66
53.33
581.30
8.63
70
25.58
72.83
715.35
2,309.85
30.09
636.40
25.65
57
49.23
36.99
1,720.90
1,476.95
30.16
86.70
25.47
32
58.82
44.04
249.25
792.88
#1 7.66
1,436.10
35.04
6
-1,081.25
42.74
277.90
197.29
17.55
63.00
#1 248.07
7
133.33
30.14
116.00
80.79
65.08
36.90
6.34
1
0.00
46.58
63.50
65.36
77.96
13.60
-8.11
-3
#1 142.86
38.65
Growth Rate
Revenue Growth
32.67 %
Net Income Growth
400.00 %
Cash Flow Change
-85.65 %
ROE
305.26 %
ROCE
252.31 %
EBITDA Margin (Avg.)
43.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
9
12
9
16
11
17
15
16
15
19
20
Expenses
8
11
9
15
10
16
14
15
14
18
20
EBITDA
1
1
-0
1
1
1
1
1
1
1
1
Operating Profit %
7 %
7 %
-2 %
5 %
7 %
6 %
8 %
4 %
6 %
6 %
3 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
-1
0
0
1
1
0
1
1
0
Tax
0
0
-0
0
0
0
0
0
0
0
0
Net Profit
0
0
-1
0
0
1
1
0
0
1
0
EPS in ₹
0.13
0.17
-0.27
0.16
0.18
0.32
0.29
0.06
0.18
0.26
0.07

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
92
91
97
108
Fixed Assets
20
19
17
16
Current Assets
67
68
76
88
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
72
72
80
92
Total Liabilities
92
91
97
108
Current Liabilities
13
11
12
8
Non Current Liabilities
3
3
4
4
Total Equity
77
77
82
97
Reserve & Surplus
61
61
65
75
Share Capital
16
16
17
20

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
-0
-1
-1
1
Investing Activities
-0
-0
0
-0
Operating Activities
0
-1
-7
-13
Financing Activities
-0
0
5
14

Share Holding

% Holding
Mar 2021
Sept 2021
Mar 2022
Sept 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Oct 2024
Dec 2024
Mar 2025
Promoter
35.70 %
34.89 %
27.60 %
22.21 %
22.21 %
19.27 %
19.27 %
16.12 %
16.12 %
16.12 %
15.66 %
18.95 %
18.26 %
19.46 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
7.80 %
7.80 %
7.80 %
7.80 %
0.00 %
6.53 %
6.53 %
6.34 %
6.09 %
5.87 %
5.68 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
50.02 %
53.14 %
59.37 %
57.42 %
58.56 %
58.59 %
58.54 %
48.93 %
52.31 %
50.78 %
49.44 %
47.51 %
48.92 %
47.83 %
Others
14.28 %
11.97 %
13.03 %
12.57 %
11.43 %
14.33 %
14.38 %
34.95 %
25.05 %
26.57 %
28.57 %
27.45 %
26.95 %
27.03 %
No of Share Holders
877
899
865
914
897
1,116
1,645
2,041
2,737
3,002
3,154
3,154
3,416
3,614

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 27.41 24.26
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 28.19 29.10
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 28.87 27.19

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 11, 2025
Board Meeting Outcome for Outcome Of Board MeetingApr 11, 2025
Board Meeting Intimation for Allotment Of Equity SharesApr 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingApr 01, 2025
Board Meeting Intimation for Allotment Of Equity SharesMar 27, 2025
Closure of Trading WindowMar 27, 2025
Integrated Filing (Financial)Mar 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Statement Of Deviation For The Quarter Ended 31St December 2024Feb 14, 2025
Quarter Ended 31St December 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of Board MeetingFeb 14, 2025
Board Meeting Intimation for Declaring Quarterly Results For Period Ended 31St December 2024Feb 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 31, 2024
Closure of Trading WindowDec 27, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 18, 2024
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations, 2015Nov 16, 2024
Intimation Of Application Filed With BSE For Approval Of Promoter ReclassificationNov 15, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 15, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 15, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Compliance-Regulation 32-Statement Of Deviation(S)/Variation(S)Nov 14, 2024
Financial Results For The Quarter Ended 30 September 2024Nov 14, 2024
Board Meeting Outcome for For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended September 2024Nov 14, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone & Consolidated) Along With The Limited Review Report Thereon For The Half Year Ended 30 September 2024Nov 09, 2024
Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments ThereofOct 21, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Dt October 21, 2024 Of The CompanyOct 21, 2024
Board Meeting Intimation for Conversion Of Warrants Into Equity Shares And Reclassification Of Promoter/Promoter Group To PublicOct 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Intimation Of Request Received For Reclassification From Promoter And Promoter Group Pursuant To The Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments ThereofOct 07, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2024
Notice Of 28Th Annual General MeetingSep 04, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
Intimation Of Book ClosureSep 04, 2024
28Th Annual General Meeting Will Be Held On 27Th September 2024 At 02:30 PM And Book ClosureSep 04, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
Notice Of 28Th Annual General MeetingSep 04, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Dated 02 September 2024Sep 02, 2024
Board Meeting Intimation for Fixing The Date And Time Of 28Th Annual General Meeting Of The Company And Other Business.Aug 28, 2024
Company Update-Deccan Health Care LimitedAug 28, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2024
Compliance-Regulation 32-Statement Of Deviation(S)/Variation(S)Jul 31, 2024
Financial Result June 2024Jul 31, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 31 July 2024 For Approval Of Financial Result For The Quarter Ended June 2024 And Other MattersJul 31, 2024

Technical Indicators

RSI(14)
Neutral
47.28
ATR(14)
Less Volatile
1.26
STOCH(9,6)
Neutral
41.14
STOCH RSI(14)
Neutral
47.84
MACD(12,26)
Bullish
0.04
ADX(14)
Strong Trend
30.74
UO(9)
Bearish
47.34
ROC(12)
Downtrend And Accelerating
-3.41
WillR(14)
Neutral
-47.09